Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 03, 2023

Rivaroxaban Use to Prevent Major Clinical Outcomes in Non-Hospitalised Patients With COVID-19



Additional Info

Disclosure statements are available on the authors' profiles:

Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE - COALITION VIII randomised clinical trial
EClinicalMedicine 2023 Jun 01;60(2023)102004, Á Avezum, HA Oliveira Junior, PDMM Neves, LBO Alves, AB Cavalcanti, RG Rosa, VC Veiga, LCP Azevedo, SL Zimmermann, OM Silvestre, RC Seabra Prudente, AP Morales Kormann, FR Moreira, I Boszczowski, E de Brito Sobrinho, A da Silva E Souza, R Seligman, B de Souza Paolino, A Razuk, A Diogenes de Magalhaes Feitosa, PL Monteiro Belmonte, P Freitas das Neves Gonçalves, ME Hernandes, AL Fagundes, JM Sarmet Esteves, AP Tognon, J Eikelboom, O Berwanger, RD Lopes, GBF Oliveira

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading